Epibatidine and pain - PubMed

Affiliations

• PMID: 9771274
• DOI: 10.1093/bja/81.1.69

Free article

Review

Epibatidine and pain

J R Traynor. Br J Anaesth. 1998 Jul.

Free article

Similar articles

• [Epibatidine. An old work principle rediscovered].

  Hecker T, Nieber K. Hecker T, et al. Med Monatsschr Pharm. 1999 Aug;22(8):226-32. Med Monatsschr Pharm. 1999. PMID: 10481433 Review. German. No abstract available.

• Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: an update.

  Yogeeswari P, Sriram D, Ratan Bal T, Thirumurugan R. Yogeeswari P, et al. Nat Prod Res. 2006 May 10;20(5):497-505. doi: 10.1080/14786410600604583. Nat Prod Res. 2006. PMID: 16644549

• Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.

  Kesingland AC, Gentry CT, Panesar MS, Bowes MA, Vernier JM, Cube R, Walker K, Urban L. Kesingland AC, et al. Pain. 2000 May;86(1-2):113-8. doi: 10.1016/s0304-3959(00)00233-5. Pain. 2000. PMID: 10779668

• [Novel analgesics: neuronal nicotinic acetylcholine receptor agonists].

  Li LJ, Liu CG. Li LJ, et al. Sheng Li Ke Xue Jin Zhan. 2001 Oct;32(4):324-7. Sheng Li Ke Xue Jin Zhan. 2001. PMID: 12545860 Review. Chinese. No abstract available.

• Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.

  Damaj MI, Martin BR. Damaj MI, et al. Eur J Pharmacol. 1996 Apr 4;300(1-2):51-7. doi: 10.1016/0014-2999(95)00834-9. Eur J Pharmacol. 1996. PMID: 8741164

Cited by

• Epibatidine: A Promising Natural Alkaloid in Health.

  Salehi B, Sestito S, Rapposelli S, Peron G, Calina D, Sharifi-Rad M, Sharopov F, Martins N, Sharifi-Rad J. Salehi B, et al. Biomolecules. 2018 Dec 23;9(1):6. doi: 10.3390/biom9010006. Biomolecules. 2018. PMID: 30583611 Free PMC article. Review.

• Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin.

  Bernardini N, Sauer SK, Haberberger R, Fischer MJ, Reeh PW. Bernardini N, et al. J Neurosci. 2001 May 1;21(9):3295-302. doi: 10.1523/JNEUROSCI.21-09-03295.2001. J Neurosci. 2001. PMID: 11312314 Free PMC article.

• Diastereoselective [3 + 2] Cycloaddition between Tertiary Amine N-Oxides and Substituted Alkenes to Access 7-Azanorbornanes.

  Cocolas AH, Lane AM, Musiak BS, Chartier EJ, Bedillion DA, Hejnosz SL, Rohde JJ, Lummis PA, Evanseck JD, Montgomery TD. Cocolas AH, et al. Org Lett. 2024 Aug 9;26(31):6546-6550. doi: 10.1021/acs.orglett.4c02013. Epub 2024 Jul 22. Org Lett. 2024. PMID: 39038111 Free PMC article.

• From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery.

  Bordon KCF, Cologna CT, Fornari-Baldo EC, Pinheiro-Júnior EL, Cerni FA, Amorim FG, Anjolette FAP, Cordeiro FA, Wiezel GA, Cardoso IA, Ferreira IG, de Oliveira IS, Boldrini-França J, Pucca MB, Baldo MA, Arantes EC. Bordon KCF, et al. Front Pharmacol. 2020 Jul 24;11:1132. doi: 10.3389/fphar.2020.01132. eCollection 2020. Front Pharmacol. 2020. PMID: 32848750 Free PMC article. Review.

• Subgroup-elimination transcriptomics identifies signaling proteins that define subclasses of TRPV1-positive neurons and a novel paracrine circuit.

  Isensee J, Wenzel C, Buschow R, Weissmann R, Kuss AW, Hucho T. Isensee J, et al. PLoS One. 2014 Dec 31;9(12):e115731. doi: 10.1371/journal.pone.0115731. eCollection 2014. PLoS One. 2014. PMID: 25551770 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information